(Q61921788)

English

Safety and Efficacy Study of Lithium in Bipolar Disorder

clinical trial

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

clinical trial

0 references

title

Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder (English)

0 references

medical condition

bipolar disorder

0 references

country

United States of America

0 references

start time

January 2007

0 references

number of participants

206

0 references

research intervention

lithium carbonate

0 references

clinical trial phase

phase III clinical trial

0 references

research subject recruitment status

unknown

0 references

minimum age

18 year

0 references

maximum age

65 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00422331

0 references

(Q61921788)

Safety and Efficacy Study of Lithium in Bipolar Disorder

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)